REFERENCES
- Blake C. (2008) Cold Chain Distribution for pharmaceuticals, MHRA <http://www.mhra.gov.uk/home/groups/isinsp/documents/websiteresources/con028448.pdf> (Accessed: May 2013)
- Bulgarian Drug Agency <www.bda.bg> (Accessed: 31 May 2013)
- Bulgarian Law on Medicinal Products in Human Medicine (2007) State Gazette, 31/13.04.2007. (In Bulgarian)
- Directive (2004) Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001o) n the Community Code relating to medicinal products for human use, OJ No L— 311, 28/11/2004, 67–128.
- Draksiene G. (2002) Medicina, 38, 488–490.
- Draksiene G., Petkevicius H., Radziunas R. (2003) Medicina, 39(Suppl. 2), 4–8.
- Félix-Picaut A. (2006) S.T.P. Pharma Pratiques, 16, 375–382.
- Guidelines (1992) Guidelines on Good Distribution Practice of Medicinal Products for Human Use (94/c 63/03), OJ No L 113, 30.4.1992, p. 1.
- Kermani F. (2010) Pharmaceutical Technology Europe, 22(8), www.pharmtech.com.
- Mitchell A. (2005) Pharm. Technol. Eur. 17: 38–43.
- Regulation (2007) Regulation No 39/13.09.2007 on principles and requirements for Good Distribution Practice, State Gazette, 77/25.09.2007. (In Bulgarian).
- Regulation (2008) Regulation No 9/23.04.2008 on conditions and requirements for recall of medicinal products non-compliant with quality, safety and efficacy requirements, State Gazette, 45/13.05.2008. (In Bulgarian).
- Stoimenova A., Petrova G. (2009) Health Policy and Management, 9, 75–84.
- World Health Organization (2003) Good Manufacturing Practices for pharmaceutical products: main principles, WHO Technical Report Series, 908, 36–89.
- World Health Organization (2010) Good Distribution Practices (GDP) for pharmaceutical products, WHO Technical Report Series, 957, 235–264.
- Zimmerman C., Kilpatric M. (2006) Journal of Pharmacy Practice, 19, 236–238.